Company intelligence / Profile preview

Mosaic Neuroscience

Epalinges, Vaud, Switzerland

Ownership: Private
Development stage: Other

Overview

Mosaic Neurosciences Sàrl aims to discover and develop therapeutics and diagnostics addressing stroke and neurodegenerative diseases, targeting both therapeutic and diagnostic approaches. Current programs appear to be in the preclinical/discovery phase; there is no public evidence of advanced clinical trials or formal clinical results

Therapeutic areas: Neurology
Modalities: ProteinPeptidesSmall molecule
Industry: Biotech

Beyond the preview

Go deeper on Mosaic Neuroscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mosaic Neuroscience.

Explore the full profile